Eco Animal Health Group PLC Investor Presentation covering Full Year Results
12 July 2024 - 6:30PM
RNS Non-Regulatory
RNS Number : 2144W
Eco Animal Health Group PLC
12 July 2024
12 July 2024
ECO Animal Health Group
plc
(''ECO"
or the "Company")
Investor Presentation
covering Full Year Results
ECO Animal Health Group plc (AIM:
EAH), a rapidly growing global animal health company with a
portfolio of marketed veterinary products and a maturing
proprietary R&D pipeline, is pleased to announce that David
Hallas, CEO, and Christopher Wilks, CFO, will be conducting a live
presentation covering the Group's Full Year results for the period
ended 31 March 2024.
The online presentation will take
place on Tuesday 16 July at 16:00 BST. This event is open to
all existing and potential shareholders and registration is free.
Questions can be submitted during the presentation and will be
addressed at the end of it.
To register for the event,
please
click here.
A video recording of the
presentation will be available shortly
afterwards here.
Contacts:
|
ECO Animal
Health Group plc
David Hallas (CEO)
Christopher Wilks (CFO)
|
020 8447 8899
|
|
Singer Capital
Markets (Nominated Adviser & Joint Broker)
Phil Davies
Sam Butcher
|
020 7496 3000
|
|
Investec
(Joint Broker)
Gary Clarence
Lydia Zychowska
|
020 7597 5970
|
|
Equity
Development
Hannah Crowe
Matt Evans
|
020 7065 2692
|
|
ICR Consilium
(Financial PR)
Mary-Jane Elliott
Jessica Hodgson
|
020 3709 5700
ecoanimalhealth@consilium-comms.com
|
About ECO Animal Health
ECO Animal Health is a world leader
in animal health, developing and marketing branded veterinary
pharmaceuticals globally, with expertise in antibiotics and
vaccines for pigs and poultry. We have a maturing proprietary
R&D pipeline.
Headquartered in the UK, with global
offices including R&D and manufacturing, we have marketing
authorisations in over 70 countries and employ over 200 people
worldwide.
Our lead product, Aivlosin® is a
proprietary, patented medication which is effective against both
respiratory and intestinal diseases in pigs and
poultry.
Click here for more
information: https://ecoanimalhealth.com
This information is provided by Reach, the non-regulatory
press release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NRAGPUWAMUPCUMP
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Nov 2024 to Dec 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Dec 2023 to Dec 2024
